688180.SH
君实生物-U
SSE · Healthcare · Biotechnology · CN
CNY 34.85
−6.87%Margins
Gross margin
80.9%
EBITDA margin
-26.3%
EBIT margin
-27.4%
Net margin
-24.3%
FCF margin
-47.6%
-11.2%
Return on equity
-4.7%
Return on assets
-7.3%
Return on invested capital
0.21x
Asset turnover
-CNY 437.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026